Speedinvest is one of Europe’s most active early-stage investors, with more than €1bn AUM, 40 investors, and offices in Berlin, London, Munich, Paris, Vienna and San Francisco.  Your success is our priority, so we don’t just send some money and ''check in'' at board meetings. Our mission is to empower you with game-changing support through every stage of your journey.  Our focused investment teams know your industry inside and out. Their Deep Tech, Fintech, Industrial Tech, Network Effects, Digital Health and Subscriptions experience, know-how and deep networks are yours from day one.  You also have full access to our in-house Platform+ team of operational experts who can provide tailored growth marketing, people (HR), US business development, and networking support throughout every stage of your journey.

Speedinvest

Giant backs purpose-driven founders building companies that matter.

Giant Ventures

The Bertelsmann Investments division pools Bertelsmann's holdings in startups around the world.

Bertelsmann Investments

General Catalyst is a venture capital firm that provides early-stage and growth equity investments. The company provides ongoing momentum that accelerates ideas, careers, and companies toward standout success.

General Catalyst

KHP Ventures is an investment firm that provides innovative ideas for healthcare.

KHP Ventures

Lakestar is a venture capital firm investing in technology companies led by exceptional entrepreneurs. Early investments included Skype, Spotify, Facebook, and Airbnb. Since raising the first fund in 2013, Lakestar manages an aggregated volume of over EUR 1bn across three early-stage funds, and more recently a growth fund.  The company has expanded and broadened its portfolio and holds investments in the likes of Opendoor, Oscar, GetYourGuide, Glovo, Sender, Eigen, Five, Revolut, and Hometogo to name a few. Lakestar has a presence in Berlin, Zurich, and London. Lakestar helps companies to identify new markets and expand into them rapidly, with a focus on the US and Europe. The team advises and supports portfolio companies in business development, recruitment, technology, and marketing. The investments range from early-stage companies to those in their growth stage.

Lakestar

Elaia is an independent venture capital firm, focused on the digital economy and deep tech. With over €700m under management, Elaia invests in high-potential disruptive startups from the first financing rounds to the emergence of global leaders. With more than 75 years of cumulated experience in both venture capital and digital industries, the investment team offers close, proactive, and relevant support to its entrepreneurs. Elaia was founded in 2002 by Philippe Gire and Xavier Lazarus and is based in Paris, Ile-de-France, France.

Elaia

Doccla

Doccla is the virtual ward company. We are the pioneers of tech-agnostic virtual wards. We partner with care organisations to enable early discharge and prevent hospital readmission by monitoring patients remotely using best of breed devices.   Doccla’s Covid-19 support service evolved from a research project we were running for the NHS, and was designed collaboratively with Northampton General Hospital, where the service is now in live use.

UK-based Doccla provides remote patient monitoring solutions to UK-based hospitals enabling them to offer “virtual wards” to patients diagnosed with chronic obstructive pulmonary disease and other heart health-related conditions. The company’s solution includes both a monitoring platform, EHR connectivity, and the integration of connected devices. Doccla also handles tasks such as software integration, logistics, and customer support.

More important now than ever, telehealth will long outlast the pandemic that drove its growth.

Telehealth

Doccla is a virtual ward technology provider that enables remote patient monitoring, allowing hospitals to discharge patients early while continuing their care at home. Founded in Sweden in 2019 and now headquartered in London, Doccla's platform allows clinical staff to monitor patients' vital signs remotely using sensors and wearable devices. The company provides an end-to-end solution that includes pre-configured smartphones, medical devices to measure parameters like heart rate and blood pressure, software integration, logistics, and customer support.

Doccla raises £15m to monitor patients remotely in ‘virtual’ wards

Doccla – Europe’s leading virtual hospital

Virtual ward company Doccla raises £15 million to enable early discharge of patients

Remote Patient Monitoring Startup Doccla Secures $17 Million Funding For 'Virtual Wards'

UK medtech firm Doccla enhances virtual ward services with OpenTeleHealth acquisition

Doccla acquires OTH in bid to become Europe’s leading virtual hospital

Healthtech Startup Doccla Raises £15 Million to Scale up Adoption of its Virtual Ward Technology

Winter is coming: how Doccla’s virtual ward pathways support Urgent and Emergency Care

Hospitals at home: Doccla hopes virtual wards can solve healthcare woes

Hertfordshire NHS trust says virtual wards prevent admissions

Virtual ward' startup Doccla gets Series A injection as it eyes AI tools

Meet Doccla, the virtual ward keeping patients out of hospital unless they absolutely need to be there

Solent NHS Trust trials virtual wards with Doccla tech

Joined Up Care Derbyshire partner with Doccla to launch virtual wards

Redefining hospital care with the comfort of home

Hospital-at-Home

Virtual ward startup Doccla raises £35m

UK-based Doccla provides remote patient monitoring solutions to UK-based hospitals enabling them to offer “virtual wards” to patients diagnosed with chronic obstructive pulmonary disease and other heart health-related conditions. The company’s solution includes both a monitoring platform, EHR connectivity, and the integration of connected devices. Doccla also handles tasks such as software integration, logistics, and customer support.As of September 2022, the company works with several NHS trusts across the UK and the company claims its platform is present in 20% of all Integrated Care Systems (ICS) in the UK.In August 2023, the company acquired Denmark-based remote patient monitoring solution <a href="https://sp-edge.com/companies/335894">OpenTeleHealth </a>for an undisclosed sum. The acquisition was carried out to help Doccla expand its operations internationally; the company now operates in 13 countries across Europe and Asia. Through the acquisition, OpenTeleHealth’s workforce became a part of Doccla’s team, along with its technology and clients. Doccla—which previously incorporated OpenTeleHealth’s technology into its offerings—continued to use this technology to cover almost 10,000 patient lives.

<div>
 
 Nice Healthcare is a US based telehealth company with a focus on primary care services to business-to-business (B2B) clients. Once the employer signs its employees with Nice (at a cost of USD 30 to USD 36 per employee per month), employees do not have to incur out of pocket expenses for Nice services and can schedule virtual or home visits within the time frames specified by the company. It connects patients with practitioners through a mobile app over video calls or text messages. Members can also request home visits which will be completed within a few hours, as claimed by the company. As of March 2022, Nice was operating in twelve states, and had over 400 small and medium enterprises (SMEs).
 
 
 In March 2022, the company raised USD 30 million in Series A financing led by DNA Capital which has been earmarked to expand its platform&rsquo;s reach among small and medium businesses. Additionally, the company is hiring three members for its management team to support the continuing growth of the organization.
 
 
 
</div>

Nice Healthcare

Amicomed is a cloud-based Software-as-a-Service (SaaS) platform which provides blood pressure monitoring services. It collects blood pressure data of patients from at-home devices, applies algorithms, and assesses the fluctuations in the blood pressure. Physicians can be connected and provided with blood pressure data of their patients in order to facilitate their workload, enabling more personalized management of patients regarding medication and lifestyle indications.Amicomed can also recommend actionable and personalized lifestyle interventions such as daily diet and exercises via virtual coaching.

Amicomed

Winston is a men’s health telemedicine platform that treats common issues impacting men such as sexual problems, hair loss, acne, and cold sores. Winston allows patients to consult doctors, place orders for prescription drugs, and offers free delivery to the homes of patients.The Toronto-based company aims to avoid men deferring doctor visits or withholding sensitive information. The consultation fee is covered by the provincial health plan, but the prescriptions are billed to the customer.

Winston

<div>
 
 Dialogue partners with employers and health insurers to offer telehealth services to their employees and members. The users have 24/7 access to doctors, nurses, and other healthcare professionals via audio, video, and chat options for wide arrays of physical and mental health needs, artificial intelligence-enabled (AI-enabled) triage, referrals, and prescription renewals. 
 
 
 The company launched its trademarked Integrated Health Platform in January 2021 to consolidate its virtual care, wellness programs, mental healthcare services, and Employee Assistance Program (EAP) onto a single platform. The company claims to be the only integrated health and wellness B2B platform in Canada. 
 
 
 Key Customers and partnerships
 
 
 Dialogue had direct relationships with over 2,000 customers across Canada and Germany as of December 2020 and served around 50,000 organizations through these partnerships. In addition, the number of members with access to the virtual platform topped 1 million in January 2021. 
 
 
 Fundings and financials
 
 
 As of March 2021, Dialogue was planning to raise CAD 100 million (USD 80 million) from an initial public offering that will be listed on the Toronto Stock Exchange under the ticker symbol &ldquo;CARE.&rdquo; 
 
 
 In Q2 2023, net losses reduced significantly YoY to CAD 5.8 million (USD 4.3 million) from CAD 8.4 million (USD 6.3 million) in Q2 2022. Top-line revenue met internal expectations, growing 17.2% YoY to CAD 25.5 million (USD 19.0 million), driven by &nbsp;an increase in new members (by 18.6% YoY), 
 an expansion of the attach rate as existing customers added more services, and full-quarter contributions from Tictrac.
 
 Dialogue Health has not provided any forward-looking guidance as the company has entered into an agreement to be 
 <a href="https://investors.dialogue.co/English/news/news-details/2023/Dialogue-to-be-Acquired-by-Sun-Life/default.aspx">
 acquired by financial services company Sun Life Financial
 </a>
 for a consideration of CAD 365 million (USD 270 million) or CAD 5.15 (USD 3.82) per share. The transaction is expected to close in Q4 2023. Post acquisition, Dialogue will delist from the Toronto Stock Exchange but will continue to operate as a standalone entity under the &ldquo;Sun Life Canada&rdquo; brand from its head office in Qu&eacute;bec. 
 
 
 
</div>

Dialogue

Grin offers telemedicine and remote monitoring services for orthodontic needs such as braces and teeth straightening. Patients can conduct self-scans (using a Grin device made available to patients in collaboration with 3M) which can be connected to their smartphones and share the feed with orthodontists to access dental solutions. The company plans to go to a subscription-based model after the pandemic. The app also encourages patients to have a 40-second check monthly and share the scan with a dentist in order to allow patients to regularly maintain their dental hygiene.Grin is the only Telehealth disruptor covered on the hub that provides virtual orthopaedic consultations.Funding and financialsIn April 2021, the New York-based teledental platform concluded a seed funding of USD 14 million, and the funds will be allocated to develop additional functionalities by building out its technology. The proceeds will also be used to scale up its team, expand its geographic footprint, and add doctors to the company’s orthodontic partner network.

Grin

Real-time collection of patients’ health-related data using any remote patient monitoring device combined with general telemedicine services to reduce readmission rates. 


A platform that facilitates the transmission of patient data to different locations for further evaluation and interpretation by medical specialists. 


A digital platform that offers specialty care services to address the specific needs of a patient or demographic, including consultations where patients are generally reluctant to meet practitioners face-to-face.

Primary care through virtual consultations for general health-related concerns using a digital platform or mobile app. 

Companies developing B2B software solutions for patient engagement, care navigation, practice management, and electronic health records integration to facilitate telehealth services for healthcare providers. 

IoT is used by most telehealth providers to operate virtual services

All telehealth players are involved in digital health via virtual offerings

Industry players offer varying degrees of personalization for each target audience

Some players offer technology and platforms to healthcare providers, converting physical-only services into virtual services

Specific telehealth offerings focus on diversity and inclusion, providing care to LGBTQ+ or BIPOC populations

Generative AI is used to streamline administrative tasks such as clinical note-taking

Doccla is a virtual ward technology provider that enables remote patient monitoring, allowing hospitals to discharge patients early while continuing their care at home. Founded in Sweden in 2019 and now headquartered in London, Doccla's platform allows clinical staff to monitor patients' vital signs remotely using sensors and wearable devices. The company provides an end-to-end solution that includes pre-configured smartphones, medical devices to measure parameters like heart rate and blood pressure, software integration, logistics, and customer support.
Doccla's technology covers over 40 clinical pathways and can be deployed within weeks. The company claims to have saved thousands of bed days for the NHS and achieved a 29% reduction in emergency admissions and a 20% reduction in A&E attendance for its client health trusts as of September 2022. Doccla reported monitoring over 50,000 "patient days" by that time. The company states it has a patient compliance rate exceeding 95% and provides an independently verified saving of GBP three for every GBP one spent by the NHS.
In August 2023, Doccla acquired OpenTeleHealth (OTH), a medically certified cloud-based platform, expanding its presence to 13 countries including 10 in Europe. This acquisition allowed Doccla to monitor almost 10,000 patients actively. The company aims to become Europe's leading virtual hospital and has expanded its services to include virtual clinical trials for the pharmaceutical industry.

<div>
 
 AdaptHealth is a network of full-service medical equipment companies that provides tailored products and services to enable patients to live their best lives at home rather than in hospitals. The company offers a wide range of medical equipment and supplies, including CPAP machines, oxygen units, walkers, and compression socks. AdaptHealth's business model focuses on delivering healthcare solutions that fit into patients' everyday lives, with offerings that span from doctor's prescriptions to doorstep delivery.
 
 
 
 
 The company emphasizes customer service and satisfaction as its primary concern, providing online support to answer questions and a team of customer service representatives to help patients choose the right supplies. AdaptHealth also offers fast and convenient shipping directly to patients' homes. In November 2020, AdaptHealth acquired New England Home Medical Equipment (NEHME), a leading supplier of continuous glucose monitoring (CGM) and diabetes management supplies in the New England and Northeastern US. NEHME generated net revenues of approximately USD 31 million for the twelve months ended September 30, 2020, contributing to AdaptHealth's expansion in the diabetes care sector.
 
 
 
 
 Key customers and partnerships
 
 
 
 
 
 AdaptHealth serves a diverse range of patients with various medical needs, including those requiring CPAP machines for sleep apnea, oxygen therapy, mobility aids, and diabetes management supplies. The company's customer base includes individuals with chronic medical conditions who require ongoing support and medical equipment. Through its acquisition of NEHME, AdaptHealth expanded its reach to diabetes patients throughout New England and the Northeastern US.
 
</div>

AdaptHealth

DispatchHealth is a Denver-based healthcare company that provides comprehensive in-home medical care services across the US. Founded in 2013, the company aims to transform healthcare delivery by offering high-acuity care in the comfort of patients' homes. DispatchHealth's services include same-day urgent medical care, hospital alternative care, and recovery care. The company employs teams of emergency medicine and internal medicine trained professionals, including nurse practitioners, physician assistants, and emergency medical technicians, who are equipped with advanced medical tools and technologies to treat a wide range of conditions typically handled in emergency rooms or urgent care centers.
DispatchHealth's care model utilizes a proprietary technology platform that manages various aspects of the in-home care experience, including logistics, onboarding, risk stratification, care coordination, and analytics. This platform enables real-time data insights to improve patient outcomes. The company's services are designed to reduce unnecessary emergency room visits, hospital stays, and readmissions, resulting in significant cost savings for the healthcare system. As of December 2023, DispatchHealth reported treating more than one million patients across more than 30 states, leading to a 58% reduction in emergency room visits, an 8.5% 30-day hospital readmission rate, and nearly USD 1.5 billion in medical cost savings.
Key customers and partnerships
DispatchHealth has established partnerships with various healthcare stakeholders, including health plans, provider groups, health systems, employers, senior living facilities, and home health organizations. In May 2023, the company announced a collaboration with Included Health to enhance virtual-to-in-home care delivery, enabling Included Health's virtual primary care clinicians to coordinate with DispatchHealth's in-home clinical services.
DispatchHealth also formed a partnership with Instacart in January 2024 to address food insecurity among patients. This collaboration allows DispatchHealth's medical professionals to provide digital food stipends, offer medically tailored shopping lists, and send food directly to patients' homes.
In the Spokane area, DispatchHealth partnered with MultiCare Health System in August 2019 to improve healthcare access for at-risk patient populations. The company works with almost all major insurance companies, including Medicare and parts of Medicaid, to reduce the cost of care significantly.

DispatchHealth

Honor Technology, Inc. is a home care company that operates a technology-enabled platform to provide care services for older adults. Founded in 2014, Honor combines local care, 24/7 support, and advanced technology through its proprietary Honor Care Platform. This platform utilizes dynamic scheduling software and machine learning to optimize caregiver-client matching based on skills, commute times, and other factors. It also assists with caregiver recruiting, training, scheduling, and performance analysis.
In August 2021, Honor acquired Home Instead, one of the largest home care providers globally. This acquisition expanded Honor's reach significantly, with the combined company representing over USD 2.1 billion in revenue as of October 2021. Honor's technology aims to improve efficiency and care quality across its network of caregivers and partner agencies.
The company offers various services through different arms of its business. Honor Expert, launched in April 2022, is an online and mobile service that connects older adults and their families with resources, tools, and services related to aging and health issues. Honor also operates the Honor Care Network, which partners with independent home care agencies to provide back-office support, technology, and operational expertise in exchange for a share of revenue.
Key customers and partnerships
Honor has established partnerships with several national companies to enhance its service offerings. As of April 2022, Honor Expert had 14 national partners, including Amazon Business, Best Buy, SelectRX, and Freshly. These partnerships aim to provide users with access to a range of products and services addressing various aging-related needs.
The company's acquisition of Home Instead significantly expanded its customer base. Home Instead operates in 12 countries and has over 600 franchised locations in the US alone. This expansion has allowed Honor to serve clients across a wider geographic area and potentially develop contracts with national insurance carriers or major health systems.
Honor also partners with independent home care agencies through its Honor Care Network. These partnerships allow smaller agencies to benefit from Honor's technology and operational capabilities while maintaining their local presence and client relationships.

Honor

Alto Pharmacy is a digital pharmacy platform founded in 2015 by former Facebook engineers Jamie Karraker and Mattieu Gamache-Asselin. The company aims to simplify the prescription process and improve medication adherence through its technology-enabled solution. Alto's platform streamlines coordination between patients, doctors, and insurance companies, offering free same-day prescription delivery, lower costs on medications, and access to pharmacist support.
Alto's services include a mobile app for patients to manage their prescriptions, set reminders, and chat with pharmacists. The company also offers Alto Connect, a mobile app for doctors' offices to streamline prescription management and communication. Alto specializes in delivering medications for various conditions, including HIV, hepatitis C, asthma, rheumatology, and cardiology, among others.
As of 2022, Alto Pharmacy operates in 13 markets across the US, including major cities like San Francisco, Los Angeles, New York, and Houston. The company has experienced rapid growth, with its annual revenue reaching USD 700 million in 2022 and projections to cross the USD 1 billion mark by the end of that year. Alto has delivered over 4 million prescriptions to hundreds of thousands of patients and claims to have provided more than USD 120 million in savings to date.

Alto Pharmacy

LetsGetChecked is a healthcare solutions company that provides at-home diagnostic testing kits and virtual care services. Founded in 2015 by Peter Foley, the company offers over 30 different health tests covering areas such as sexual health, women's health, men's health, general wellness, and Covid-19. LetsGetChecked's testing process involves customers ordering a kit online, collecting their sample at home, and mailing it back to CLIA-certified and CAP-accredited laboratories for analysis. Results are typically available within 2-5 days through a secure online portal. The company utilizes biomarkers to analyze health conditions and employs highly accurate testing methods like NAAT PCR and electrochemiluminescence arrays for certain tests. In November 2023, LetsGetChecked achieved a significant milestone when the FDA granted marketing authorization for its Simple 2 Test, the first at-home test for chlamydia and gonorrhea. The company has expanded its services to include telehealth consultations and prescription delivery, aiming to provide a comprehensive healthcare solution. LetsGetChecked operates its own manufacturing facilities and laboratories, allowing for quality control throughout the testing process. As of 2024, the company has delivered over 7 million tests and serves more than 30 markets globally.
Key customers and partnerships
LetsGetChecked has partnered with over 300 corporate customers to provide testing services and biometric screening solutions. The company has also collaborated with major retailers and healthcare providers. In 2023, LetsGetChecked announced a partnership with PatientsLikeMe (PLM), a community health network, to offer PLM members access to testing at discounted prices. Additionally, the company has worked with UnitedHealthcare, Optum, HSA Store, FSA Store, and CVS Pharmacy. LetsGetChecked's services are available nationwide in the US, the UK, and most EU countries, with co-headquarters in Dublin and New York.

LetsGetChecked

Digital platforms that connect patients with in-person medical care providers in the comfort of their homes and support care delivery

Platforms enabling healthcare providers to order in-home therapies, durable medical equipment, and provide virtual acute care services

Companies offering a full-stack of in-home medical services including health evaluations, virtual and in-person visits for a variety of needs, and care coordination by leveraging data analytics

Platforms providing accessible lab testing solutions for a range of conditions, allowing patients to conveniently perform tests in their own homes

Digital pharmacies that deliver prescription medications directly to patients' homes and platforms that help track and manage medication adherence

Solutions enabling hospitals to establish hospital-at-home programs and providing workflow management tools for home care providers

<div>

 Doccla, a provider of virtual ward services, has raised GBP 35 million in a Series B funding round. The funding was led by Lakestar, with participation from Elaia, General Catalyst, Bertelsmann Investments, and Speedinvest, bringing Doccla's total funds raised to GBP 54.6 million.
 
 These funds will help Doccla expand its operations across Europe, specifically in France, Germany, Austria, and Switzerland, while also strengthening its position in the UK and Ireland.
 
 Following the funding round, Lakestar partner Oliver Heimes will join Doccla's board.&nbsp;
 
 Doccla's virtual ward solution, which offers 24/7 patient monitoring on 40 different pathways, has observed millions of patient days throughout Europe. Studies show that this solution has led to a 63% decrease in A&amp;E attendance and a 300% return on investment.

</div>

Doccla

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless